INTERPACE BIOSCIENCES, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Interpace Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Interpace Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$600K, a 100% decline year-over-year.
  • Interpace Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$5.03M, a 268% decline from 2022.
  • Interpace Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3M, a 66.6% decline from 2021.
  • Interpace Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $8.98M, a 45.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.03M -$8.03M -268% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $3M -$5.98M -66.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $8.98M -$7.63M -45.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $16.6M -$12.6M -43.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $29.2M +$29.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-04-01
2018 -$9K -$29.9M -100% Jan 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
2017 $29.9M +$30M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 -$101K +$21.3M +99.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 -$21.4M -$40.6M -211% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $19.2M +$19.5M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 -$314K -$158K -101% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-05
2012 -$156K -$140K -875% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-06
2011 -$16K +$46K +74.2% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-15
2010 -$62K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.